Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb crossover study of KH176 on cognitive function in adults with mitochondrial m.3243A>G mutation
2019-000599-40Phase 2Completed
- Sponsor
- Khondrion
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sonlicromanol in Mitochondriopathy (3 arms), sponsored by Khondrion. Primary endpoint: Change in attention domain score. Started Jul 2019; status: completed.
02
Drugs
sonlicromanol
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on 2019-000599-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000599-40.